PULM
Pulmatrix Inc
NASDAQ: PULM · HEALTHCARE · BIOTECHNOLOGY
$1.26
+1.61% today
Updated 2026-04-30
Market cap
$4.67M
P/E ratio
—
P/S ratio
2,459.21x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$1 – $9
Volume
0.1M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$10.00
+693.65%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-706000.00
- Revenue declining -99.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.07M | $7.30M | $7.81M | $0.00 | $3000.00 |
| Net income | $-18.73M | $-14.12M | $-9.56M | $-5.16M | $-928000.00 |
| EPS | — | — | — | — | $-1.41 |
| Free cash flow | $-19.44M | $-16.66M | $-11.11M | $-5.43M | $-706000.00 |
| Profit margin | -308.43% | -193.49% | -122.46% | — | — |
Peer comparison
Smart narrative
Pulmatrix Inc trades at $1.26. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $3000.00.
Frequently asked questions
What is Pulmatrix Inc's stock price?
Pulmatrix Inc (PULM) trades at $1.26.
Is Pulmatrix Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Pulmatrix Inc (PULM)?
The analyst target price is $10.00, representing +693.7% upside from the current price of $1.26.
What is Pulmatrix Inc's revenue?
TTM revenue is $3000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2,459.21x
ROE-80.90%
Beta1.97
50D MA$1.89
200D MA$3.68
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—